Brais Lauren K - ‖ Department of Medical Oncology, Dana-Farber Cancer Institute

基本信息

浏览量：60

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 210 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Figure 3 from ras/raf Comutation and erbb2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

Harshabad Singh,Pranshu Sahgal,Kevin S. Kapner,Steven M. Corsello, Hersh Gupta,Rahul Gujrathi,Yvonne Li, Andrew D. Cherniack,Raquelle El Alam,Joseph Kerfoot,Elizabeth Andrews, Annette Lee,Chetan Nambiar,Alison M. Hannigan,Joshua Remland,Lauren K. Brais,Meghan E. Leahy, Douglas A. Rubinson,Benjamin L. Schlechter, Matthew Meyerson,Yanan Kuang, Cloud P. Paweletz, Jessica Lee,Júlia C.F. Quintanilha, Andrew J. Aguirre,Kimberly Perez,Brandon M. Huffman,Humberto Rossi, Thomas A. Abrams,Sheheryar Kabraji,Livio Trusolino,Andrea Bertotti,Ewa T. Sicinska, Aparna R. Parikh, Brian M. Wolpin, Alexa B. Schrock, Marios Giannakis, Kimmie Ng, Jeffrey A. Meyerhardt,Jason L. Hornick,Nilay S. Sethi, James M. Cleary

openalex

引用0浏览0引用

Supplementary Figure 4 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

引用0浏览0引用

Supplementary Table 9 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

引用0浏览0引用

Epigenetic and oncogenic inhibitors cooperatively drive differentiation and kill KRAS-mutant colorectal cancers

Patrick Loi,Amy E Schade,Carrie L Rodriguez, Anjana Krishnan,Naiara Perurena, Van T M Nguyen, Yilin Xu,Marina Watanabe,Rachel A Davis,Alycia Gardner,Natalie F Pilla,Kaia Mattioli,Olesja Popow,Nuray Gunduz,Tamsin R M Lannagan, Samantha Fitzgerald,Ewa T Sicinska,Jia-Ren Lin, William Tan,Lauren K Brais,Kevin M Haigis,Marios Giannakis,Kimmie Ng,Sandro Santagata,Kristian Helin, Owen J Sansom, Karen Cichowski

Cancer discovery (2024)

引用0浏览0WOS引用

Supplementary Table 2 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

引用0浏览0引用

Supplementary Figure 3 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

引用0浏览0引用

Supplementary Methods 1 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

引用0浏览0引用

Supplementary Table 4 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

引用0浏览0引用

Supplementary Figure 6 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

引用0浏览0引用

Supplementary Table 4 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn